Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
QLS7305 Injection
DRUG
2 trials
Sponsors
Qilu Pharmaceutical Co., Ltd.
Conditions
C3 Glomerulopathy (C3G)
Healthy Volunteers - Male and Female
IgAN - IgA Nephropathy
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Primary Membranous Nephropathy
Phase 1
A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults
Not yet recruiting
NCT07313150
Qilu Pharmaceutical Co., Ltd.
Healthy Volunteers - Male and Female
Start: 2026-01-31
End: 2027-12-31
Target: 60
Updated: 2025-12-31
Phase 2
Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)
Not yet recruiting
NCT07730632
Qilu Pharmaceutical Co., Ltd.
C3 Glomerulopathy (C3G), IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) +1
Start: 2026-08-10
End: 2028-08-11
Target: 60
Updated: 2026-07-28